APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

CRISPR Gene Editing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global CRISPR Gene Editing Service Market Analysis and Forecast 2026-2032

Report ID 174106320217 January 2026190 pages

Choose your research edition.

Industry ResearchCRISPR Gene Editing Service Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal CRISPR Gene Editing Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal CRISPR Gene Editing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CRISPR Gene Editing Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal CRISPR Gene Editing Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global CRISPR Gene Editing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for CRISPR Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for CRISPR Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for CRISPR Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for CRISPR Gene Editing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of CRISPR Gene Editing Service include AMSBIO, GenScript, Merck, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, DefiniGEN, Synthego and Biocytogen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for CRISPR Gene Editing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of CRISPR Gene Editing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for CRISPR Gene Editing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CRISPR Gene Editing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global CRISPR Gene Editing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for CRISPR Gene Editing Service revenue, projected growth trends, production technology, application and end-user industry.

CRISPR Gene Editing Service Segment by Company

AMSBIO

GenScript

Merck

Editas Medicine

Intellia Therapeutics

CRISPR Therapeutics

DefiniGEN

Synthego

Biocytogen

Caribou

Horizo​​n Discovery Ltd.

EdiGene, Inc.

DetaiBio

CRISPR Gene Editing Service Segment by Type

CRISPR-Cas9

CRISPR-Cas12a (Cpf1)

Other

CRISPR Gene Editing Service Segment by Application

Cell Line Construction

Animal Models

Bioagriculture

Other

CRISPR Gene Editing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR Gene Editing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CRISPR Gene Editing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR Gene Editing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of CRISPR Gene Editing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of CRISPR Gene Editing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CRISPR Gene Editing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CRISPR Gene Editing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CRISPR-Cas9 Major Player Table 3. CRISPR-Cas12a (Cpf1) Major Player Table 4. Other Major Player Table 5. Global CRISPR Gene Editing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cell Line Construction Major Player Table 7. Animal Models Major Player Table 8. Bioagriculture Major Player Table 9. Other Major Player Table 10. CRISPR Gene Editing Service Industry Trends Table 11. CRISPR Gene Editing Service Industry Drivers Table 12. CRISPR Gene Editing Service Industry Opportunities and Challenges Table 13. CRISPR Gene Editing Service Industry Restraints Table 14. Global CRISPR Gene Editing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global CRISPR Gene Editing Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global CRISPR Gene Editing Service Market Share by Region (2021-2026) Table 17. Global CRISPR Gene Editing Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global CRISPR Gene Editing Service Market Share by Region (2027-2032) Table 19. Global CRISPR Gene Editing Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global CRISPR Gene Editing Service Revenue Market Share by Players (2021-2026) Table 21. Global CRISPR Gene Editing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global CRISPR Gene Editing Service Key Players Headquarters & Area Served Table 23. Global CRISPR Gene Editing Service Players, Product Type & Application Table 24. Global CRISPR Gene Editing Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global CRISPR Gene Editing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global CRISPR Gene Editing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global CRISPR Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global CRISPR Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global CRISPR Gene Editing Service Revenue Market Share by Type (2021-2026) Table 31. Global CRISPR Gene Editing Service Revenue Market Share by Type (2027-2032) Table 32. Global CRISPR Gene Editing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global CRISPR Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global CRISPR Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global CRISPR Gene Editing Service Revenue Market Share by Application (2021-2026) Table 36. Global CRISPR Gene Editing Service Revenue Market Share by Application (2027-2032) Table 37. AMSBIO Company Information Table 38. AMSBIO Business Overview Table 39. AMSBIO CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. AMSBIO CRISPR Gene Editing Service Product Portfolio Table 41. AMSBIO Recent Development Table 42. GenScript Company Information Table 43. GenScript Business Overview Table 44. GenScript CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. GenScript CRISPR Gene Editing Service Product Portfolio Table 46. GenScript Recent Development Table 47. Merck Company Information Table 48. Merck Business Overview Table 49. Merck CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Merck CRISPR Gene Editing Service Product Portfolio Table 51. Merck Recent Development Table 52. Editas Medicine Company Information Table 53. Editas Medicine Business Overview Table 54. Editas Medicine CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Editas Medicine CRISPR Gene Editing Service Product Portfolio Table 56. Editas Medicine Recent Development Table 57. Intellia Therapeutics Company Information Table 58. Intellia Therapeutics Business Overview Table 59. Intellia Therapeutics CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Intellia Therapeutics CRISPR Gene Editing Service Product Portfolio Table 61. Intellia Therapeutics Recent Development Table 62. CRISPR Therapeutics Company Information Table 63. CRISPR Therapeutics Business Overview Table 64. CRISPR Therapeutics CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. CRISPR Therapeutics CRISPR Gene Editing Service Product Portfolio Table 66. CRISPR Therapeutics Recent Development Table 67. DefiniGEN Company Information Table 68. DefiniGEN Business Overview Table 69. DefiniGEN CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. DefiniGEN CRISPR Gene Editing Service Product Portfolio Table 71. DefiniGEN Recent Development Table 72. Synthego Company Information Table 73. Synthego Business Overview Table 74. Synthego CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Synthego CRISPR Gene Editing Service Product Portfolio Table 76. Synthego Recent Development Table 77. Biocytogen Company Information Table 78. Biocytogen Business Overview Table 79. Biocytogen CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Biocytogen CRISPR Gene Editing Service Product Portfolio Table 81. Biocytogen Recent Development Table 82. Caribou Company Information Table 83. Caribou Business Overview Table 84. Caribou CRISPR Gene Editing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Caribou CRISPR Gene Editing Service Product Portfolio Table 86. Caribou Recent Development Table 87. Horizo​​n Discovery Ltd. Company Information Table 88. Horizo​​n Discovery Ltd. Business Overview Table 89. Horizo​​n Discovery Ltd. CRISPR Gene Editing Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Horizo​​n Discovery Ltd. CRISPR Gene Editing Service Product Portfolio Table 91. Horizo​​n Discovery Ltd. Recent Development Table 92. EdiGene, Inc. Company Information Table 93. EdiGene, Inc. Business Overview Table 94. EdiGene, Inc. CRISPR Gene Editing Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. EdiGene, Inc. CRISPR Gene Editing Service Product Portfolio Table 96. EdiGene, Inc. Recent Development Table 97. DetaiBio Company Information Table 98. DetaiBio Business Overview Table 99. DetaiBio CRISPR Gene Editing Service Sales (Unit), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. DetaiBio CRISPR Gene Editing Service Product Portfolio Table 101. DetaiBio Recent Development Table 102. North America CRISPR Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 103. North America CRISPR Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 104. North America CRISPR Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 105. North America CRISPR Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 106. North America CRISPR Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America CRISPR Gene Editing Service Revenue by Country (2021-2026) & (US$ Million) Table 108. North America CRISPR Gene Editing Service Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe CRISPR Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe CRISPR Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe CRISPR Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe CRISPR Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe CRISPR Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe CRISPR Gene Editing Service Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe CRISPR Gene Editing Service Revenue by Country (US$ Million) & (2027-2032) Table 116. China CRISPR Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 117. China CRISPR Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 118. China CRISPR Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 119. China CRISPR Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia CRISPR Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia CRISPR Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia CRISPR Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia CRISPR Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia CRISPR Gene Editing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia CRISPR Gene Editing Service Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia CRISPR Gene Editing Service Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA CRISPR Gene Editing Service Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA CRISPR Gene Editing Service Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA CRISPR Gene Editing Service Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA CRISPR Gene Editing Service Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA CRISPR Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA CRISPR Gene Editing Service Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA CRISPR Gene Editing Service Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. CRISPR Gene Editing Service Image Figure 2. Global CRISPR Gene Editing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CRISPR Gene Editing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. CRISPR-Cas9 Image Figure 5. CRISPR-Cas12a (Cpf1) Image Figure 6. Other Image Figure 7. Global CRISPR Gene Editing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global CRISPR Gene Editing Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cell Line Construction Image Figure 10. Animal Models Image Figure 11. Bioagriculture Image Figure 12. Other Image Figure 13. Global CRISPR Gene Editing Service Market Size (US$ Million) & (2021-2032) Figure 14. Global CRISPR Gene Editing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global CRISPR Gene Editing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global CRISPR Gene Editing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global CRISPR Gene Editing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global CRISPR Gene Editing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global CRISPR Gene Editing Service Revenue Market Share by Type (2021-2032) Figure 21. Global CRISPR Gene Editing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global CRISPR Gene Editing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global CRISPR Gene Editing Service Revenue Market Share by Application (2021-2032) Figure 24. North America CRISPR Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America CRISPR Gene Editing Service Revenue Share by Type (2021-2032) Figure 26. North America CRISPR Gene Editing Service Revenue Share by Application (2021-2032) Figure 27. North America CRISPR Gene Editing Service Revenue Share by Country (2021-2032) Figure 28. United States CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe CRISPR Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe CRISPR Gene Editing Service Revenue Share by Type (2021-2032) Figure 33. Europe CRISPR Gene Editing Service Revenue Share by Application (2021-2032) Figure 34. Europe CRISPR Gene Editing Service Revenue Share by Country (2021-2032) Figure 35. Germany CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China CRISPR Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China CRISPR Gene Editing Service Revenue Share by Type (2021-2032) Figure 45. China CRISPR Gene Editing Service Revenue Share by Application (2021-2032) Figure 46. Asia CRISPR Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia CRISPR Gene Editing Service Revenue Share by Type (2021-2032) Figure 48. Asia CRISPR Gene Editing Service Revenue Share by Application (2021-2032) Figure 49. Asia CRISPR Gene Editing Service Revenue Share by Region (2021-2032) Figure 50. Japan CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA CRISPR Gene Editing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA CRISPR Gene Editing Service Revenue Share by Type (2021-2032) Figure 58. SAMEA CRISPR Gene Editing Service Revenue Share by Application (2021-2032) Figure 59. SAMEA CRISPR Gene Editing Service Revenue Share by Country (2021-2032) Figure 60. Brazil CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt CRISPR Gene Editing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • CRISPR-Cas9
  • CRISPR-Cas12a (Cpf1)
  • Other
Applications
  • Cell Line Construction
  • Animal Models
  • Bioagriculture
  • Other
Companies covered
  • AMSBIO
  • GenScript
  • Merck
  • Editas Medicine
  • Intellia Therapeutics
  • CRISPR Therapeutics
  • DefiniGEN
  • Synthego
  • Biocytogen
  • Caribou
  • Horizo​​n Discovery Ltd.
  • EdiGene, Inc.
  • DetaiBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 CRISPR Gene Editing Service Market by Type
  3. 1.2.1 Global CRISPR Gene Editing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CRISPR-Cas9
  5. 1.2.3 CRISPR-Cas12a (Cpf1)
  6. 1.2.4 Other
  7. 1.3 CRISPR Gene Editing Service Market by Application
  8. 1.3.1 Global CRISPR Gene Editing Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cell Line Construction
  10. 1.3.3 Animal Models
  11. 1.3.4 Bioagriculture
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 CRISPR Gene Editing Service Market Dynamics
  1. 2.1 CRISPR Gene Editing Service Industry Trends
  2. 2.2 CRISPR Gene Editing Service Industry Drivers
  3. 2.3 CRISPR Gene Editing Service Industry Opportunities and Challenges
  4. 2.4 CRISPR Gene Editing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global CRISPR Gene Editing Service Market Perspective (2021-2032)
  2. 3.2 Global CRISPR Gene Editing Service Growth Trends by Region
  3. 3.2.1 Global CRISPR Gene Editing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global CRISPR Gene Editing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global CRISPR Gene Editing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global CRISPR Gene Editing Service Revenue by Players
  2. 4.1.1 Global CRISPR Gene Editing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global CRISPR Gene Editing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global CRISPR Gene Editing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global CRISPR Gene Editing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global CRISPR Gene Editing Service Key Players Headquarters & Area Served
  7. 4.4 Global CRISPR Gene Editing Service Players, Product Type & Application
  8. 4.5 Global CRISPR Gene Editing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global CRISPR Gene Editing Service Market CR5 and HHI
  11. 4.6.3 2025 CRISPR Gene Editing Service Tier 1, Tier 2, and Tier 3
5 CRISPR Gene Editing Service Market Size by Type
  1. 5.1 Global CRISPR Gene Editing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global CRISPR Gene Editing Service Revenue by Type (2021-2032)
  3. 5.3 Global CRISPR Gene Editing Service Revenue Market Share by Type (2021-2032)
6 CRISPR Gene Editing Service Market Size by Application
  1. 6.1 Global CRISPR Gene Editing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global CRISPR Gene Editing Service Revenue by Application (2021-2032)
  3. 6.3 Global CRISPR Gene Editing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AMSBIO
  2. 7.1.1 AMSBIO Company Information
  3. 7.1.2 AMSBIO Business Overview
  4. 7.1.3 AMSBIO CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AMSBIO CRISPR Gene Editing Service Product Portfolio
  6. 7.1.5 AMSBIO Recent Developments
  7. 7.2 GenScript
  8. 7.2.1 GenScript Company Information
  9. 7.2.2 GenScript Business Overview
  10. 7.2.3 GenScript CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GenScript CRISPR Gene Editing Service Product Portfolio
  12. 7.2.5 GenScript Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Merck CRISPR Gene Editing Service Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Editas Medicine
  20. 7.4.1 Editas Medicine Company Information
  21. 7.4.2 Editas Medicine Business Overview
  22. 7.4.3 Editas Medicine CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Editas Medicine CRISPR Gene Editing Service Product Portfolio
  24. 7.4.5 Editas Medicine Recent Developments
  25. 7.5 Intellia Therapeutics
  26. 7.5.1 Intellia Therapeutics Company Information
  27. 7.5.2 Intellia Therapeutics Business Overview
  28. 7.5.3 Intellia Therapeutics CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Intellia Therapeutics CRISPR Gene Editing Service Product Portfolio
  30. 7.5.5 Intellia Therapeutics Recent Developments
  31. 7.6 CRISPR Therapeutics
  32. 7.6.1 CRISPR Therapeutics Company Information
  33. 7.6.2 CRISPR Therapeutics Business Overview
  34. 7.6.3 CRISPR Therapeutics CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CRISPR Therapeutics CRISPR Gene Editing Service Product Portfolio
  36. 7.6.5 CRISPR Therapeutics Recent Developments
  37. 7.7 DefiniGEN
  38. 7.7.1 DefiniGEN Company Information
  39. 7.7.2 DefiniGEN Business Overview
  40. 7.7.3 DefiniGEN CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 DefiniGEN CRISPR Gene Editing Service Product Portfolio
  42. 7.7.5 DefiniGEN Recent Developments
  43. 7.8 Synthego
  44. 7.8.1 Synthego Company Information
  45. 7.8.2 Synthego Business Overview
  46. 7.8.3 Synthego CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Synthego CRISPR Gene Editing Service Product Portfolio
  48. 7.8.5 Synthego Recent Developments
  49. 7.9 Biocytogen
  50. 7.9.1 Biocytogen Company Information
  51. 7.9.2 Biocytogen Business Overview
  52. 7.9.3 Biocytogen CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Biocytogen CRISPR Gene Editing Service Product Portfolio
  54. 7.9.5 Biocytogen Recent Developments
  55. 7.10 Caribou
  56. 7.10.1 Caribou Company Information
  57. 7.10.2 Caribou Business Overview
  58. 7.10.3 Caribou CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Caribou CRISPR Gene Editing Service Product Portfolio
  60. 7.10.5 Caribou Recent Developments
  61. 7.11 Horizo​​n Discovery Ltd.
  62. 7.11.1 Horizo​​n Discovery Ltd. Company Information
  63. 7.11.2 Horizo​​n Discovery Ltd. Business Overview
  64. 7.11.3 Horizo​​n Discovery Ltd. CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Horizo​​n Discovery Ltd. CRISPR Gene Editing Service Product Portfolio
  66. 7.11.5 Horizo​​n Discovery Ltd. Recent Developments
  67. 7.12 EdiGene, Inc.
  68. 7.12.1 EdiGene, Inc. Company Information
  69. 7.12.2 EdiGene, Inc. Business Overview
  70. 7.12.3 EdiGene, Inc. CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 EdiGene, Inc. CRISPR Gene Editing Service Product Portfolio
  72. 7.12.5 EdiGene, Inc. Recent Developments
  73. 7.13 DetaiBio
  74. 7.13.1 DetaiBio Company Information
  75. 7.13.2 DetaiBio Business Overview
  76. 7.13.3 DetaiBio CRISPR Gene Editing Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 DetaiBio CRISPR Gene Editing Service Product Portfolio
  78. 7.13.5 DetaiBio Recent Developments
8 North America
  1. 8.1 North America CRISPR Gene Editing Service Revenue (2021-2032)
  2. 8.2 North America CRISPR Gene Editing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America CRISPR Gene Editing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America CRISPR Gene Editing Service Revenue by Type (2027-2032)
  5. 8.3 North America CRISPR Gene Editing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America CRISPR Gene Editing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America CRISPR Gene Editing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America CRISPR Gene Editing Service Revenue by Application (2027-2032)
  9. 8.5 North America CRISPR Gene Editing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America CRISPR Gene Editing Service Revenue by Country
  11. 8.6.1 North America CRISPR Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America CRISPR Gene Editing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America CRISPR Gene Editing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe CRISPR Gene Editing Service Revenue (2021-2032)
  2. 9.2 Europe CRISPR Gene Editing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe CRISPR Gene Editing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe CRISPR Gene Editing Service Revenue by Type (2027-2032)
  5. 9.3 Europe CRISPR Gene Editing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe CRISPR Gene Editing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe CRISPR Gene Editing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe CRISPR Gene Editing Service Revenue by Application (2027-2032)
  9. 9.5 Europe CRISPR Gene Editing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe CRISPR Gene Editing Service Revenue by Country
  11. 9.6.1 Europe CRISPR Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe CRISPR Gene Editing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe CRISPR Gene Editing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China CRISPR Gene Editing Service Revenue (2021-2032)
  2. 10.2 China CRISPR Gene Editing Service Revenue by Type (2021-2032)
  3. 10.2.1 China CRISPR Gene Editing Service Revenue by Type (2021-2026)
  4. 10.2.2 China CRISPR Gene Editing Service Revenue by Type (2027-2032)
  5. 10.3 China CRISPR Gene Editing Service Revenue Share by Type (2021-2032)
  6. 10.4 China CRISPR Gene Editing Service Revenue by Application (2021-2032)
  7. 10.4.1 China CRISPR Gene Editing Service Revenue by Application (2021-2026)
  8. 10.4.2 China CRISPR Gene Editing Service Revenue by Application (2027-2032)
  9. 10.5 China CRISPR Gene Editing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia CRISPR Gene Editing Service Revenue (2021-2032)
  2. 11.2 Asia CRISPR Gene Editing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia CRISPR Gene Editing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia CRISPR Gene Editing Service Revenue by Type (2027-2032)
  5. 11.3 Asia CRISPR Gene Editing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia CRISPR Gene Editing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia CRISPR Gene Editing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia CRISPR Gene Editing Service Revenue by Application (2027-2032)
  9. 11.5 Asia CRISPR Gene Editing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia CRISPR Gene Editing Service Revenue by Country
  11. 11.6.1 Asia CRISPR Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia CRISPR Gene Editing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia CRISPR Gene Editing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA CRISPR Gene Editing Service Revenue (2021-2032)
  2. 12.2 SAMEA CRISPR Gene Editing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA CRISPR Gene Editing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA CRISPR Gene Editing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA CRISPR Gene Editing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA CRISPR Gene Editing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA CRISPR Gene Editing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA CRISPR Gene Editing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA CRISPR Gene Editing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA CRISPR Gene Editing Service Revenue by Country
  11. 12.6.1 SAMEA CRISPR Gene Editing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA CRISPR Gene Editing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA CRISPR Gene Editing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst